Protego Biopharma
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3210 Merryfield Row, San Diego, Californ...Phone Number
(858) 242-1518Website
www.protegobiopharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
2
1
1
1
About Protego Biopharma
Protego BioPharma is dedicated to the discovery and development of first-in-class small molecule therapeutics aimed at addressing protein misfolding diseases, which pose significant challenges in medical research. The company employs a data-driven approach to target unmet medical needs through innovative drug discovery and translational research, focusing on pharmacological chaperones to restore protein stability. Their work is rooted in the principles of protein homeostasis and aims to enhance cellular capacity for protein folding, thereby addressing chronic degenerative diseases. Intended clients include patients suffering from various degenerative conditions such as myopathy, cardiomyopathy, and other related diseases.Explore more
Popular SearchesProtego BiopharmaProtego Biopharma IncProtegoSIC Code 87,873NAICS Code 54,541Show moreProtego Biopharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Protego Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Protego Biopharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Protego Biopharma
Check if Protego Biopharma has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Protego Biopharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Protego Biopharma recently announced quarterly report
Click to see if Protego Biopharma had a recent Job posting/layoffs
Protego Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Protego Biopharma is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Protego Biopharma as Masked Content
Find more new buyers
Compare Similar Companies to Protego Biopharma
Compare insights from companies similar to Protego Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Protego Biopharma is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Protego Biopharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Protego Biopharma.
Protego Biopharma financials insights
Gather financial insights about Protego Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$51M
Protego Biopharma Tech Stack
A closer look at the technologies used by Protego Biopharma
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Protego Biopharma is planning to move offices in November 2024. The move will impact approximately 27 employees at the existing office located at 10945 Vista Sorrento Pkwy, San Diego, CA.
Facilities Relocation/Expansion
New Hire
Executive Move
Executive Moves, New Hire
Funding
Funding
Protego Biopharma News & Media
Protego Biopharma Lands $130 Million Oversubscribed Series B Financing
SAN DIEGO, CA, Protego Biopharma, a clinical-stage biotechnology company, announced the completion of an oversubscribed $130 million Series B financing.Protego Biopharma Raises $130 Million Oversubscribed Series B Financing to Advance First-in-Class AL Amyloidosis Program into Pivotal Study
Financing led by Novartis Venture Fund and Forbion, with new investment from Omega Funds, Droia Ventures, YK Bioventures, and Digitalis Ventures Renewed backing from Vida Ventures, MPM BioImpact, Lightspeed Venture Partners, and Scripps Research SAN DIEGO, Dec. 1, 2025 /PRNewswire/ --...Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of ...
- Lightspeed Venture Partners and Vida Ventures join seed investor MPM Capital to lead Series A financing - - Protego’s proprietary technology platforms based on pioneering work from the Scripps Research labs of Dr.s Jeffery W. Kelly and R. Luke Wiseman - SAN DIEGO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Protego Biopharma, Inc., a preclinical-stage biotechnology company dedicated to finding novel solutions for protein misfolding diseases, today announced it has raised $51 million in
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Protego Biopharma
Sign Up For FreeTo access detailed company insights
Protego BioPharma is dedicated to the discovery and development of first-in-class small molecule therapeutics aimed at addressing protein misfolding diseases, which pose significant challenges in medical research. The company employs a data-driven approach to target unmet medical needs through innovative drug discovery and translational research, f... Read More
